Corrado Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Corrado Advisors's BMY Position: Q1 2025 in Review
Corrado Advisors sold out of Bristol-Myers Squibb (BMY) in Q1 2025, closing a stake of 27,887 shares — an estimated $1.58M sold.
Corrado Advisors first reported a position in BMY in Q1 2019 and held it in 24 quarters. The position peaked at $3.52M in Q4 2019. 2,477 funds tracked by Wall St. Rank hold BMY as of Q1 2025.
- Corrado Advisors reported no remaining Bristol-Myers Squibb position as of Q1 2025 after selling out during the quarter.
- Corrado Advisors sold 27,887 Bristol-Myers Squibb shares in Q1 2025, an estimated $1.58M.
- Corrado Advisors first reported a position in Bristol-Myers Squibb in Q1 2019 and held it in 24 quarters.
- Corrado Advisors's Bristol-Myers Squibb position peaked at $3.52M in Q4 2019.
- 2,477 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2025.
Based on Corrado Advisors's 13F filing for Q1 2025, filed 1 May 2025.